Lincoln Pharmaceuticals P/B Ratio

Current P/B Ratio
2.05
Moderate Valuation
High - Premium to book value, growth expectations or asset-light model

Lincoln Pharmaceuticals (LINCOLN) P/B ratio is 2.05 (Moderate), book value per share ₹336.00 vs Healthcare average P/B of -0.33 — High - Premium to book value, growth expectations or asset-light model. Compare with LINCOLN fair value estimate to assess whether the stock is under or overvalued.

Current Valuation Metrics

P/B Ratio 2.05
Current Price ₹758.15
Book Value/Share ₹336.00
Exchange NSE

Book Value Breakdown (2025)

Balance Sheet Components
Total Equity ₹672 Cr
Share Capital ₹20 Cr
Reserves & Surplus ₹652 Cr
Outstanding Shares 20,000,000
Book Value per Share ₹336.00

Valuation Signal

Signal Fairly Valued
Historical Avg 2.02
Historical Range 1.44 - 2.66
Percentile 60.0%

Sector Context

Sector Average -0.33
Sector Median 0.63
Sector Rank #11 of 50
Sector Percentile 22.0%

LINCOLN P/B Ratio — Valuation Insights & Book Value Analysis

Lincoln Pharmaceuticals price-to-book ratio interpretation, valuation status and historical context — current P/B 2.05 (Moderate). View LINCOLN yearly price range for the annual high/low range and current price position.

  • Trading at premium to sector average PB of -0.33

Lincoln Pharmaceuticals P/B Ratio Historical Trend

LINCOLN annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. For live price, earnings yield and the full fundamental profile, see Lincoln Pharmaceuticals screener.

LINCOLN Historical P/B Ratio — Book Value Per Share & Year-End Price

Lincoln Pharmaceuticals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.

Year P/B Ratio Book Value/Share (₹) Year-end Price (₹) Total Equity (₹ Cr) Valuation
2025 1.44 ₹336.0 ₹483.95 ₹672 Moderate
2024 2.66 ₹296.5 ₹787.80 ₹593 Moderate
2023 2.42 ₹251.5 ₹609.50 ₹503 Moderate
2022 1.64 ₹216.5 ₹355.55 ₹433 Moderate
2021 1.96 ₹183.0 ₹358.25 ₹366 Moderate

LINCOLN vs Healthcare Peers — P/B Ratio Comparison

Lincoln Pharmaceuticals P/B 2.05 vs Healthcare average -0.33, median 0.63 — range -17.92–1.01.

Sector Average
-0.33
Sector Median
0.63
Lowest P/B
-17.92
Highest P/B
1.01
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Rekvina Laboratories VINRKLB -17.92 ₹22 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Parmax Pharma PARMAX -2.48 ₹14 Low
Bharat Immunologicals BIBCL -2.32 ₹76 Low
Krebs Biochemicals & Ind… KREBSBIO -0.71 ₹127 Low
Cresanto Global CRESANTO -0.7 ₹2 Low
Vivimed Labs VIVIMEDLAB -0.63 ₹53 Low